Physician profile
Scott Sporer
NPI 1043299795
$5,335,606.85
in general payments reported to CMS, 2019-2025
12 companies · $1.0M in 2025
The $1.0M reported for 2025 was more than what 99% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $553K · 2020: $555K · 2021: $758K · 2022: $959K · 2023: $1.1M · 2024: $358K · 2025: $1.0M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $2.1M · Consulting Fee: $384K · Travel and Lodging: $43K · Food and Beverage: $1,742.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $2,081,185.16 |
| Consulting Fee | $384,447.50 |
| Travel and Lodging | $42,559.88 |
| Food and Beverage | $1,741.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $4,515,466.73 | 2019-2025 | Djo Surgical |
| Osteoremedies, LLC | $401,472.75 | 2019-2025 | Remedy Spacer, Remedy Spacer |
| Zimmer Biomet Holdings, INC. | $369,669.88 | 2019-2025 | Persona Partial Knee System, Persona |
| Pacira Pharmaceuticals Incorporated | $39,904.79 | 2019-2025 | |
| Insight Medical Systems, INC. | $4,658.43 | 2023-2024 | Arvis |
| Osteocentric Technologies, INC. | $3,159.74 | 2020 | |
| Djo, LLC | $650.00 | 2019 | |
| Medacta USA, INC. | $392.33 | 2021-2024 | Gmk Sphere |
| Exactech, INC. | $157.79 | 2019 | |
| Heron Therapeutics, INC. | $62.45 | 2025 | Zynrelef |
| Travere Therapeutics, INC. | $11.96 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Sporer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.